Discharge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation

被引:3
作者
Xing Fuwei
Zheng Xin
Zhang Lihua
Hu Shuang
Bai Xueke
Hu Danli
Li Bing
Li Jing
机构
[1] Department of Cardiology
[2] ChinaNational Clinical Research Center for Cardiovascular Diseases
[3] Jilin 130031
[4] Guangzhou
[5] Guangdong 510080
[6] Changchun
[7] National Center for Cardiovascular Diseases
[8] State Key Laboratory of Cardiovascular Disease
[9] Beijing 100037
[10] Chinese Academy of Medical Sciences and Peking Union Medical College
[11] Fuwai Hospital
[12] ChinaDepartment of Cardiology
[13] The Third Hospital of Jilin University
[14] NHC Key Laboratory of Clinical Research for Cardiovascular Medications
[15] The First Affiliated Hospital of Sun Yat-Sen University
基金
国科技部“十一五”科技计划项目;
关键词
Atrial fibrillation; Heart failure; Heart rate; Left ventricular ejection fraction;
D O I
暂无
中图分类号
R541.6 [血液循环衰竭]; R541.75 [];
学科分类号
1002 ; 100201 ;
摘要
Background: The association between heart rate and 1-year clinical outcomes in heart failure (HF) patients with atrial fibrillation (AF), and whether this association depends on left ventricular ejection fraction (LVEF), are unclear. We investigated the relationship between discharge heart rate and 1-year clinical outcomes after discharge among hospitalized HF patients with AF, and further explored this association that differ by LVEF level.Methods: In this analysis, we enrolled 1760 hospitalized HF patients with AF from the China Patient-centered Evaluative Assessment of Cardiac Events Prospective Heart Failure study from August 2016 to May 2018. Patients were categorized into three groups with low (<65 beats per minute [bpm]), moderate (65-85 bpm), and high (≥86 bpm) heart rate measured at discharge.Cox proportional hazard models were employed to explore the association between heart rate and 1-year primary outcome, which was defined as a composite outcome of all-cause death and HF rehospitalization.Results: Among 1760 patients, 723 (41.1%) were women, the median age was 69 (interquartile range [IQR]: 60-77) years, median discharge heart rate was 75 (IQR: 69-84) bpm, and 934 (53.1%) had an LVEF <50%. During 1-year follow-up, a total of 792 (45.0%) individuals died or had at least one HF hospitalization. After adjusting for demographic characteristics, smoking status, medical history, anthropometric characteristics, and medications used at discharge, the groups with low (hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.05-1.68,P = 0.020) and high (HR: 1.34, 95% CI: 1.07-1.67,P = 0.009) heart rate were associated with a higher risk of 1-year primary outcome compared with the moderate group. A significant interaction between discharge heart rate and LVEF for the primary outcome was observed (P for interaction was 0.045). Among the patients with LVEF ≥50%, only those with high heart rate were associated with a higher risk of primary outcome compared with the group with moderate heart rate (HR: 1.38, 95% CI: 1.01-1.89,P = 0.046), whereas there was no difference between the groups with low and moderate heart rate. Among the patients with LVEF <50%, only those with low heart rate were associated with a higher risk of primary outcome compared with the group with moderate heart rate (HR: 1.46, 95% CI: 1.09-1.96,P = 0.012), whereas there was no difference between the groups with high and moderate heart rate.Conclusions: Among the overall HF patients with AF, both low (<65 bpm) and high (≥86 bpm) heart rates were associated with poorer outcomes as compared with moderate (65-85 bpm) heart rate. Among patients with LVEF ≥50%, only a high heart rate was associated with higher risk; while among those with LVEF <50%, only a low heart rate was associated with higher risk as compared with the group with moderate heart rate.Trail Registration: Clinicaltrials.gov; NCT02878811.
引用
收藏
页码:52 / 62
页数:11
相关论文
共 17 条
  • [1] The China Patient-centred Evaluative Assessment of Cardiac Events (PEACE) prospective heart failure study design
    Huang, Xinghe
    Yu, Yuan
    Li, Xi
    Masoudi, Fredrick A.
    Spertus, John A.
    Yan, Xiaofang
    Krumholz, Harlan M.
    Jiang, Lixin
    Li, Jing
    [J]. BMJ OPEN, 2019, 9 (02):
  • [2] Effect of β-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF Pilot and ESC-HF Long-Term Registry[J] . Ozierański Krzysztof,Kap?on-Cie?licka Agnieszka,Balsam Pawe?,Tymińska Agata,Wancerz Anna,Peller Micha?,Marchel Micha?,Crespo-Leiro Maria G,Maggioni Aldo P,Dro?d? Jaros?aw,Filipiak Krzysztof J,Opolski Grzegorz.Polish archives of internal medicine . 2018 (11)
  • [3] Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis
    Simpson, Joanne
    Castagno, Davide
    Doughty, Rob N.
    Poppe, Katrina K.
    Earle, Nikki
    Squire, Iain
    Richards, Mark
    Andersson, Bert
    Ezekowitz, Justin A.
    Komajda, Michel
    Petrie, Mark C.
    McAlister, Finlay A.
    Gamble, Greg D.
    Whalley, Gillian A.
    McMurray, John J. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (11) : 1182 - 1191
  • [4] Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program
    Vazir, Ali
    Claggett, Brian
    Jhund, Pardeep
    Castagno, Davide
    Skali, Hicham
    Yusuf, Salim
    Swedberg, Karl
    Granger, Christopher B.
    McMurray, John J. V.
    Pfeffer, Marc A.
    Solomon, Scott D.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (11) : 669 - 675
  • [5] Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis[J] . Dipak Kotecha,Jane Holmes,Henry Krum,Douglas G Altman,Luis Manzano,John G F Cleland,Gregory Y H Lip,Andrew J S Coats,Bert Andersson,Paulus Kirchhof,Thomas G von Lueder,Hans Wedel,Giuseppe Rosano,Marcelo C Shibata,Alan Rigby,Marcus D Flather.The Lancet . 2014 (9961)
  • [6] Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study
    Takada, Tsuyoshi
    Sakata, Yasuhiko
    Miyata, Satoshi
    Takahashi, Jun
    Nochioka, Kotaro
    Miura, Masanobu
    Tadaki, Soichiro
    Shimokawa, Hiroaki
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (03) : 309 - 316
  • [7] Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction
    Reil, Jan-Christian
    Hohl, Mathias
    Reil, Gert-Hinrich
    Granzier, Henk L.
    Kratz, Mario T.
    Kazakov, Andrey
    Fries, Peter
    Mueller, Andreas
    Lenski, Matthias
    Custodis, Florian
    Graeber, Stefan
    Froehlig, Gerd
    Steendijk, Paul
    Neuberger, Hans-Ruprecht
    Boehm, Michael
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (36) : 2839 - 2849
  • [8] Lenient vs. strict rate control in patientswith atrial fibrillation and heart failure: A post-hoc analysis of the RACE 2 study[J] . Mulder,B.A.,VanVeldhuisen,D.J.,Crijns,H.J.G.M.,Tijssen,J.G.P.,Hillege,H.L.,Alings,M.,Rienstra,M.,Groenveld,H.F.,VanDenBerg,M.P.,VanGelder,I.C..European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2013 (11)
  • [9] Chronotropic Incompetence Causes, Consequences, and Management
    Brubaker, Peter H.
    Kitzman, Dalane W.
    [J]. CIRCULATION, 2011, 123 (09) : 1010 - 1020
  • [10] Lenient versus Strict Rate Control in Patients with Atrial Fibrillation.
    Van Gelder, Isabelle C.
    Groenveld, Hessel F.
    Crijns, Harry J. G. M.
    Tuininga, Ype S.
    Tijssen, Jan G. P.
    Alings, A. Marco
    Hillege, Hans L.
    Bergsma-Kadijk, Johanna A.
    Cornel, Jan H.
    Kamp, Otto
    Tukkie, Raymond
    Bosker, Hans A.
    Van Veldhuisen, Dirk J.
    Van den Berg, Maarten P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) : 1363 - 1373